These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 9421696

  • 21. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E, Bauersachs R.
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K, Jaumotte C, Saussoy P, Zech F, Lavenne E, Hainaut P.
    Acta Clin Belg; 2000 Oct; 55(3):176-81. PubMed ID: 10981327
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
    Horlait G, Minet V, Mullier F, Michaux I.
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):193-197. PubMed ID: 27100305
    [Abstract] [Full Text] [Related]

  • 29. On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopenia.
    Schenk JF, Pindur G, Stephan B, Mörsdorf S, Mertzlufft F, Kroll H, Wenzel E, Seyfert UT.
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):25-32. PubMed ID: 12643320
    [Abstract] [Full Text] [Related]

  • 30. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 2003 Jan; 279(16):1265-72. PubMed ID: 9565006
    [Abstract] [Full Text] [Related]

  • 31. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
    Kanagasabay R, Unsworth-White MJ, Farnsworth G, Haxby EJ, Smith EE.
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
    [No Abstract] [Full Text] [Related]

  • 32. [Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].
    Riedel R, Schmieder A, Koster A, Kim S, Baumgarten G, Schewe JC.
    Med Klin Intensivmed Notfmed; 2017 May; 112(4):334-346. PubMed ID: 28005139
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M, Claeys L, Huk I, Koppensteiner R, Kyrle PA, Minar E, Stümpflen A, Ehringer H, Polterauer P.
    Wien Klin Wochenschr; 1997 Feb 28; 109(4):128-31. PubMed ID: 9076930
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study.
    de Pont AC, Hofstra JJ, Pik DR, Meijers JC, Schultz MJ.
    Crit Care; 2007 Feb 28; 11(5):R102. PubMed ID: 17854496
    [Abstract] [Full Text] [Related]

  • 37. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R, Rachmimov R, Berliner S.
    Harefuah; 1999 Mar 01; 136(5):361-4, 419. PubMed ID: 10914239
    [Abstract] [Full Text] [Related]

  • 38. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
    Hale LP, Smith K, Braden GA, Owen J.
    Cathet Cardiovasc Diagn; 1998 Nov 01; 45(3):318-22. PubMed ID: 9829897
    [Abstract] [Full Text] [Related]

  • 39. Heparin-induced thrombocytopenia: pathophysiology and management.
    Mureebe L, Silver D.
    Vasc Endovascular Surg; 2002 Nov 01; 36(3):163-70. PubMed ID: 12075381
    [Abstract] [Full Text] [Related]

  • 40. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
    Emig U, Meyer T, Buchwald AB.
    Dtsch Med Wochenschr; 1997 Aug 01; 122(31-32):965-8. PubMed ID: 9280716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.